EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Recent advances in nanoparticulate RNA delivery systems

Jacob Witten, Yizong Hu iD, Robert Langer iD, Daniel G Anderson

Proceedings of the National Academy of Sciences · 12.03.2024 · 121 (11)

DOI: 10.1073/pnas.2307798120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.03.2024. Verfasst von Jacob Witten und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139. Hauptthemen laut MEDLINE: Antibodies, Cancer Vaccines. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, HHS | National Institutes of Health, Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticle-based RNA delivery has shown great progress in recent years with the approval of two mRNA vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and a liver-targeted siRNA therapy. Here, we discuss the preclinical and clinical advancement of new generations of RNA delivery therapies along multiple axes. Improvements in cargo design such as RNA circularization and data-driven untranslated region optimization can drive better mRNA expression. New materials discovery research has driven improved delivery to extrahepatic targets such as the lung and splenic immune cells, which could lead to pulmonary gene therapy and better cancer vaccines, respectively. Other organs and even specific cell types can be targeted for delivery via conjugation of small molecule ligands, antibodies, or peptides to RNA delivery nanoparticles. Moreover, the immune response to any RNA delivery nanoparticle plays a crucial role in determining efficacy. Targeting increased immunogenicity without induction of reactogenic side effects is crucial for vaccines, while minimization of immune response is important for gene therapies. New developments have addressed each of these priorities. Last, we discuss the range of RNA delivery clinical trials targeting diverse organs, cell types, and diseases and suggest some key advances that may play a role in the next wave of therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesCancer VaccinesRNA, Small InterferingGenetic TherapyLiverSARS-CoV-2

Substanzen

RNA, Small InterferingAntibodiesCancer Vaccines

Autor:innen und Institutionen

  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Harvard and Massachusetts Institute of Technology Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Department of Anesthesiology, Boston Children's Hospital, Boston, MA 02115.
  • Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139.

ORCID-Profile: Yizong Hu, Robert Langer

Förderung

  • NHLBI NIH HHS
  • HHS | National Institutes of Health
  • Cystic Fibrosis Foundation

Zitieren

APA

Witten, J., Hu, Y., Langer, R., & Anderson, D. G. (2024). Recent advances in nanoparticulate RNA delivery systems. Proceedings of the National Academy of Sciences, 121(11). https://doi.org/10.1073/pnas.2307798120

Vancouver

Witten J, Hu Y, Langer R, Anderson DG. Recent advances in nanoparticulate RNA delivery systems. Proceedings of the National Academy of Sciences. 2024;121(11). doi:10.1073/pnas.2307798120

BibTeX
@article{Witten2024,
  author = {Witten, Jacob and Hu, Yizong and Langer, Robert and Anderson, Daniel G},
  title = {Recent advances in nanoparticulate RNA delivery systems},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {11},
  doi = {10.1073/pnas.2307798120}
}
Kostenlos starten →